Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of isotype switching to IgG isotypes (GO:0048302) | 9.49537474 |
2 | negative T cell selection (GO:0043383) | 7.83074720 |
3 | negative thymic T cell selection (GO:0045060) | 7.77071039 |
4 | positive thymic T cell selection (GO:0045059) | 7.59173959 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.37970027 |
6 | regulation of regulatory T cell differentiation (GO:0045589) | 7.37384238 |
7 | positive T cell selection (GO:0043368) | 6.75860221 |
8 | leukocyte aggregation (GO:0070486) | 6.72032211 |
9 | positive regulation of isotype switching (GO:0045830) | 6.65155022 |
10 | thymic T cell selection (GO:0045061) | 6.62251656 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 6.57619224 |
12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.35062238 |
13 | tolerance induction (GO:0002507) | 6.33002110 |
14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.26009480 |
15 | T cell selection (GO:0045058) | 6.06877233 |
16 | response to interleukin-15 (GO:0070672) | 5.79630534 |
17 | cellular response to interleukin-15 (GO:0071350) | 5.71385939 |
18 | positive regulation of DNA recombination (GO:0045911) | 5.66902618 |
19 | regulation of isotype switching (GO:0045191) | 5.59482069 |
20 | negative regulation of cell killing (GO:0031342) | 5.53759483 |
21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.53759483 |
22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.43458427 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.43038624 |
24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.43038624 |
25 | T cell receptor signaling pathway (GO:0050852) | 5.42044999 |
26 | interferon-gamma production (GO:0032609) | 5.40867387 |
27 | T cell costimulation (GO:0031295) | 5.34361824 |
28 | lymphocyte costimulation (GO:0031294) | 5.30251197 |
29 | * regulation of immunoglobulin secretion (GO:0051023) | 5.23631673 |
30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.20535778 |
31 | positive regulation of B cell mediated immunity (GO:0002714) | 5.19956156 |
32 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.19956156 |
33 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 5.18643342 |
34 | T cell migration (GO:0072678) | 5.11897181 |
35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.05573888 |
36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.99867920 |
37 | regulation of T cell tolerance induction (GO:0002664) | 4.82840381 |
38 | endothelial cell chemotaxis (GO:0035767) | 4.82370564 |
39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.71004868 |
40 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.64640122 |
41 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.57782040 |
42 | regulation of B cell mediated immunity (GO:0002712) | 4.47676961 |
43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46470378 |
44 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.37567012 |
45 | positive regulation of immunoglobulin production (GO:0002639) | 4.37257479 |
46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.31941406 |
47 | positive regulation of humoral immune response (GO:0002922) | 4.31915856 |
48 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 4.29499602 |
49 | positive regulation of granulocyte differentiation (GO:0030854) | 4.21086088 |
50 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.18489971 |
51 | * regulation of immunoglobulin production (GO:0002637) | 4.15293068 |
52 | T cell differentiation involved in immune response (GO:0002292) | 4.10182977 |
53 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.10182977 |
54 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.10182977 |
55 | alpha-beta T cell differentiation (GO:0046632) | 4.09086993 |
56 | T cell differentiation (GO:0030217) | 4.05475213 |
57 | positive regulation of interleukin-2 production (GO:0032743) | 4.04508575 |
58 | negative regulation of T cell mediated immunity (GO:0002710) | 4.02214239 |
59 | positive regulation of tolerance induction (GO:0002645) | 3.95722959 |
60 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.95179614 |
61 | negative regulation of B cell apoptotic process (GO:0002903) | 3.93801115 |
62 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.93039094 |
63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91047381 |
64 | DNA deamination (GO:0045006) | 3.89338513 |
65 | alpha-beta T cell activation (GO:0046631) | 3.86670095 |
66 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.86384404 |
67 | positive regulation of interleukin-17 production (GO:0032740) | 3.86163546 |
68 | regulation of chronic inflammatory response (GO:0002676) | 3.85182245 |
69 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.82669635 |
70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.81675645 |
71 | NIK/NF-kappaB signaling (GO:0038061) | 3.77977780 |
72 | positive regulation of T cell differentiation (GO:0045582) | 3.70421719 |
73 | positive regulation of macrophage differentiation (GO:0045651) | 3.69985556 |
74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.64957248 |
75 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.64413569 |
76 | mast cell activation (GO:0045576) | 3.63722484 |
77 | positive regulation of astrocyte differentiation (GO:0048711) | 3.57973953 |
78 | natural killer cell activation (GO:0030101) | 3.56726511 |
79 | sequestering of actin monomers (GO:0042989) | 3.54083065 |
80 | T cell activation (GO:0042110) | 3.52482321 |
81 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.50661730 |
82 | positive regulation of activated T cell proliferation (GO:0042104) | 3.50239180 |
83 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.47727870 |
84 | positive regulation of T cell activation (GO:0050870) | 3.47441399 |
85 | T cell homeostasis (GO:0043029) | 3.46898556 |
86 | regulation of cell killing (GO:0031341) | 3.45247672 |
87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.40824546 |
88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40259486 |
89 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.40086177 |
90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.40086177 |
91 | regulation of tolerance induction (GO:0002643) | 3.39011806 |
92 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.36451907 |
93 | positive regulation of cell killing (GO:0031343) | 3.35938508 |
94 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.35686723 |
95 | regulation of response to interferon-gamma (GO:0060330) | 3.32774643 |
96 | positive regulation of lamellipodium assembly (GO:0010592) | 3.30573465 |
97 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.30507781 |
98 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.29639641 |
99 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.28721313 |
100 | myeloid dendritic cell differentiation (GO:0043011) | 3.27164645 |
101 | dendritic cell chemotaxis (GO:0002407) | 3.26155978 |
102 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.25259971 |
103 | defense response to protozoan (GO:0042832) | 3.23793873 |
104 | positive regulation of T cell migration (GO:2000406) | 3.22481905 |
105 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.19354167 |
106 | T-helper cell differentiation (GO:0042093) | 3.19354167 |
107 | positive regulation of lymphocyte differentiation (GO:0045621) | 3.18750020 |
108 | cytidine deamination (GO:0009972) | 3.18270572 |
109 | cytidine metabolic process (GO:0046087) | 3.18270572 |
110 | cytidine catabolic process (GO:0006216) | 3.18270572 |
111 | regulation of T cell differentiation (GO:0045580) | 3.17308248 |
112 | positive regulation of defense response to virus by host (GO:0002230) | 3.15058334 |
113 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.14429224 |
114 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.14429224 |
115 | myeloid dendritic cell activation (GO:0001773) | 3.14354150 |
116 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.14238601 |
117 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.14170293 |
118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13318919 |
119 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.12122631 |
120 | regulation of B cell differentiation (GO:0045577) | 3.10129750 |
121 | regulation of T cell activation (GO:0050863) | 3.09204417 |
122 | activated T cell proliferation (GO:0050798) | 3.08714028 |
123 | dendritic cell migration (GO:0036336) | 3.08572048 |
124 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.07695552 |
125 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06608387 |
126 | regulation of interleukin-2 production (GO:0032663) | 3.05901644 |
127 | regulation of respiratory burst (GO:0060263) | 3.05742033 |
128 | lymphocyte homeostasis (GO:0002260) | 3.04101326 |
129 | regulation of alpha-beta T cell activation (GO:0046634) | 3.02724644 |
130 | * leukocyte cell-cell adhesion (GO:0007159) | 3.02447330 |
131 | positive regulation of interferon-gamma production (GO:0032729) | 3.00840186 |
132 | regulation of defense response to virus by virus (GO:0050690) | 3.00212618 |
133 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.99932708 |
134 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.95371642 |
135 | positive regulation of lymphocyte migration (GO:2000403) | 2.95191252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.49061763 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.06340538 |
3 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.46366201 |
4 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 4.03292514 |
5 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.87613317 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 3.78288678 |
7 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.58000437 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.54408632 |
9 | MYB_26560356_Chip-Seq_TH2_Human | 3.47821839 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.45780662 |
11 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.14580925 |
12 | * MAF_26560356_Chip-Seq_TH1_Human | 3.11585033 |
13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.07320540 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00671733 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82793325 |
16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.79579106 |
17 | MYB_26560356_Chip-Seq_TH1_Human | 2.76821953 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72992237 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37904986 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37814930 |
21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.24621523 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18619778 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15832227 |
24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.14217337 |
25 | * MAF_26560356_Chip-Seq_TH2_Human | 2.07084774 |
26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.04173103 |
27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00328100 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98812859 |
29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.97205849 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89921732 |
31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85563937 |
32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85022763 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81404015 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79375791 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78572642 |
36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76707866 |
37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76707225 |
38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72249493 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70052359 |
40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68915037 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66124573 |
42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65801919 |
43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.64711159 |
44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.60773866 |
45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.59648904 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59245105 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57999063 |
48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51421712 |
49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46187319 |
50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45529190 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43095437 |
52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.41554033 |
53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36440409 |
54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35360543 |
55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34360499 |
56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32995101 |
57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29451405 |
58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28371033 |
59 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.27633869 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23333263 |
61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21511925 |
62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21204850 |
63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19039298 |
64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18467770 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17360785 |
66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14586510 |
67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10650532 |
68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09088546 |
69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08215286 |
70 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06950288 |
71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05627364 |
72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04073608 |
73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02396194 |
74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01622238 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00586916 |
76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99976628 |
77 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97072017 |
78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95569378 |
79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95433779 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93532633 |
81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92363468 |
82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91759443 |
83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91304523 |
84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91084919 |
85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91044647 |
86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88620957 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87993231 |
88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86581431 |
89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85826034 |
90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84754510 |
91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84535673 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82988126 |
93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82621716 |
94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82093330 |
95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81637157 |
96 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81283258 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80103126 |
98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79987409 |
99 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78246819 |
100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77258371 |
101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76817108 |
102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76712802 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76566452 |
104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74155459 |
105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73360283 |
106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73307959 |
107 | P300_27268052_Chip-Seq_Bcells_Human | 0.72741729 |
108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72230810 |
109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72023356 |
110 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69857417 |
111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69220774 |
112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68418199 |
113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.68116497 |
114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.67594695 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67512666 |
116 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66954474 |
117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.66873856 |
118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.66336065 |
119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.66204445 |
120 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.65015798 |
121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.64480731 |
122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.64428291 |
123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.63291686 |
124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.62653636 |
125 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62524488 |
126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61943823 |
127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.61899561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.72884899 |
2 | MP0005671_abnormal_response_to | 5.50223920 |
3 | MP0003300_gastrointestinal_ulcer | 4.53594598 |
4 | MP0001853_heart_inflammation | 3.49604713 |
5 | * MP0000685_abnormal_immune_system | 3.40002311 |
6 | MP0009333_abnormal_splenocyte_physiolog | 3.15273371 |
7 | MP0003436_decreased_susceptibility_to | 3.10104406 |
8 | MP0002405_respiratory_system_inflammati | 2.98008289 |
9 | MP0003866_abnormal_defecation | 2.97178281 |
10 | * MP0001835_abnormal_antigen_presentation | 2.96142327 |
11 | * MP0005000_abnormal_immune_tolerance | 2.82875752 |
12 | * MP0001800_abnormal_humoral_immune | 2.82236979 |
13 | MP0006082_CNS_inflammation | 2.77463846 |
14 | * MP0005387_immune_system_phenotype | 2.73010328 |
15 | * MP0001790_abnormal_immune_system | 2.73010328 |
16 | MP0003724_increased_susceptibility_to | 2.70816562 |
17 | MP0002166_altered_tumor_susceptibility | 2.68684026 |
18 | MP0009785_altered_susceptibility_to | 2.66406746 |
19 | * MP0002723_abnormal_immune_serum | 2.61799584 |
20 | * MP0002398_abnormal_bone_marrow | 2.58003700 |
21 | * MP0002420_abnormal_adaptive_immunity | 2.51138517 |
22 | MP0004510_myositis | 2.49650070 |
23 | * MP0001819_abnormal_immune_cell | 2.46681233 |
24 | MP0000703_abnormal_thymus_morphology | 2.42486501 |
25 | MP0000465_gastrointestinal_hemorrhage | 2.40651564 |
26 | MP0004947_skin_inflammation | 2.32478303 |
27 | * MP0002452_abnormal_antigen_presenting | 2.24156223 |
28 | * MP0005025_abnormal_response_to | 2.21282620 |
29 | MP0002933_joint_inflammation | 2.20801212 |
30 | * MP0000716_abnormal_immune_system | 2.20002341 |
31 | MP0010155_abnormal_intestine_physiology | 2.16171104 |
32 | MP0002006_tumorigenesis | 2.14104697 |
33 | * MP0002722_abnormal_immune_system | 2.01136424 |
34 | * MP0000689_abnormal_spleen_morphology | 1.99631923 |
35 | MP0003303_peritoneal_inflammation | 1.99490394 |
36 | MP0001873_stomach_inflammation | 1.88483720 |
37 | MP0002396_abnormal_hematopoietic_system | 1.82168927 |
38 | * MP0002429_abnormal_blood_cell | 1.76084665 |
39 | MP0002148_abnormal_hypersensitivity_rea | 1.72987155 |
40 | MP0001845_abnormal_inflammatory_respons | 1.62820112 |
41 | MP0005423_abnormal_somatic_nervous | 1.59055677 |
42 | MP0002419_abnormal_innate_immunity | 1.52160763 |
43 | * MP0000604_amyloidosis | 1.49114181 |
44 | MP0001533_abnormal_skeleton_physiology | 1.48393536 |
45 | MP0004808_abnormal_hematopoietic_stem | 1.46611945 |
46 | MP0002277_abnormal_respiratory_mucosa | 1.42112160 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.35056381 |
48 | MP0010352_gastrointestinal_tract_polyps | 1.34490058 |
49 | MP0005464_abnormal_platelet_physiology | 1.30181007 |
50 | MP0001851_eye_inflammation | 1.26001801 |
51 | MP0000858_altered_metastatic_potential | 1.20956457 |
52 | MP0004381_abnormal_hair_follicle | 1.18429731 |
53 | MP0005310_abnormal_salivary_gland | 1.16123082 |
54 | MP0000372_irregular_coat_pigmentation | 1.06114143 |
55 | MP0002998_abnormal_bone_remodeling | 1.03329385 |
56 | MP0003448_altered_tumor_morphology | 1.01006245 |
57 | MP0008469_abnormal_protein_level | 1.00681575 |
58 | MP0008057_abnormal_DNA_replication | 0.97458829 |
59 | MP0002822_catalepsy | 0.92219213 |
60 | MP0005023_abnormal_wound_healing | 0.91316345 |
61 | MP0008961_abnormal_basal_metabolism | 0.88662120 |
62 | MP0001881_abnormal_mammary_gland | 0.87597125 |
63 | MP0002132_abnormal_respiratory_system | 0.87111983 |
64 | MP0004742_abnormal_vestibular_system | 0.86388247 |
65 | MP0008877_abnormal_DNA_methylation | 0.84909973 |
66 | MP0002019_abnormal_tumor_incidence | 0.84134567 |
67 | MP0003453_abnormal_keratinocyte_physiol | 0.81355071 |
68 | MP0000609_abnormal_liver_physiology | 0.78005376 |
69 | MP0001986_abnormal_taste_sensitivity | 0.77248963 |
70 | MP0001348_abnormal_lacrimal_gland | 0.76052998 |
71 | MP0005076_abnormal_cell_differentiation | 0.75628898 |
72 | MP0009764_decreased_sensitivity_to | 0.74955934 |
73 | MP0003045_fibrosis | 0.73373297 |
74 | MP0000490_abnormal_crypts_of | 0.72551939 |
75 | MP0009763_increased_sensitivity_to | 0.71353980 |
76 | MP0005166_decreased_susceptibility_to | 0.71060747 |
77 | MP0002009_preneoplasia | 0.70858927 |
78 | MP0008872_abnormal_physiological_respon | 0.69584872 |
79 | MP0000627_abnormal_mammary_gland | 0.67789695 |
80 | MP0001545_abnormal_hematopoietic_system | 0.66837806 |
81 | MP0005397_hematopoietic_system_phenotyp | 0.66837806 |
82 | MP0001243_abnormal_dermal_layer | 0.66001757 |
83 | MP0005390_skeleton_phenotype | 0.63288164 |
84 | MP0002163_abnormal_gland_morphology | 0.61650905 |
85 | MP0001919_abnormal_reproductive_system | 0.61590800 |
86 | MP0001958_emphysema | 0.61177848 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.60970552 |
88 | MP0000249_abnormal_blood_vessel | 0.60581516 |
89 | MP0004130_abnormal_muscle_cell | 0.59396957 |
90 | * MP0003795_abnormal_bone_structure | 0.59153659 |
91 | MP0008569_lethality_at_weaning | 0.58507440 |
92 | MP0005381_digestive/alimentary_phenotyp | 0.57725652 |
93 | MP0004142_abnormal_muscle_tone | 0.56290986 |
94 | MP0002102_abnormal_ear_morphology | 0.56196049 |
95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.55899587 |
96 | MP0002693_abnormal_pancreas_physiology | 0.55247311 |
97 | MP0001191_abnormal_skin_condition | 0.54919885 |
98 | MP0000015_abnormal_ear_pigmentation | 0.54522966 |
99 | MP0005165_increased_susceptibility_to | 0.53066400 |
100 | MP0003943_abnormal_hepatobiliary_system | 0.52182348 |
101 | MP0004264_abnormal_extraembryonic_tissu | 0.51129452 |
102 | MP0003252_abnormal_bile_duct | 0.49444290 |
103 | MP0004782_abnormal_surfactant_physiolog | 0.48473332 |
104 | MP0001216_abnormal_epidermal_layer | 0.47081693 |
105 | MP0000477_abnormal_intestine_morphology | 0.45639176 |
106 | MP0005075_abnormal_melanosome_morpholog | 0.45111647 |
107 | MP0001765_abnormal_ion_homeostasis | 0.44618636 |
108 | MP0002876_abnormal_thyroid_physiology | 0.44277666 |
109 | MP0003786_premature_aging | 0.44277081 |
110 | MP0003806_abnormal_nucleotide_metabolis | 0.44244200 |
111 | MP0008007_abnormal_cellular_replicative | 0.41081699 |
112 | MP0003077_abnormal_cell_cycle | 0.40811890 |
113 | MP0003828_pulmonary_edema | 0.39718493 |
114 | MP0001663_abnormal_digestive_system | 0.39420917 |
115 | MP0005083_abnormal_biliary_tract | 0.38708292 |
116 | MP0000920_abnormal_myelination | 0.38673837 |
117 | MP0002136_abnormal_kidney_physiology | 0.38542483 |
118 | MP0004883_abnormal_blood_vessel | 0.36141472 |
119 | MP0001501_abnormal_sleep_pattern | 0.35098785 |
120 | MP0002083_premature_death | 0.34162780 |
121 | MP0008873_increased_physiological_sensi | 0.33929624 |
122 | MP0000598_abnormal_liver_morphology | 0.33384747 |
123 | MP0000367_abnormal_coat/_hair | 0.33186430 |
124 | MP0010234_abnormal_vibrissa_follicle | 0.31155816 |
125 | MP0000613_abnormal_salivary_gland | 0.28284949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Severe combined immunodeficiency (HP:0004430) | 7.21311863 |
2 | T lymphocytopenia (HP:0005403) | 6.96813572 |
3 | Abnormality of T cell number (HP:0011839) | 6.77876605 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.42290803 |
5 | Combined immunodeficiency (HP:0005387) | 6.33720059 |
6 | * Stomatitis (HP:0010280) | 6.21141853 |
7 | Eczematoid dermatitis (HP:0000976) | 5.76564894 |
8 | Recurrent bronchitis (HP:0002837) | 5.30274503 |
9 | IgM deficiency (HP:0002850) | 5.22030197 |
10 | Increased density of long bones (HP:0006392) | 5.10641937 |
11 | * IgG deficiency (HP:0004315) | 5.09187827 |
12 | * Abnormality of T cells (HP:0002843) | 4.85369943 |
13 | Chronic diarrhea (HP:0002028) | 4.77939336 |
14 | Recurrent fungal infections (HP:0002841) | 4.76846716 |
15 | Panhypogammaglobulinemia (HP:0003139) | 4.76692375 |
16 | Gastrointestinal infarctions (HP:0005244) | 4.51413357 |
17 | Nasal polyposis (HP:0100582) | 4.42223506 |
18 | Abnormality of B cell number (HP:0010975) | 4.39303434 |
19 | B lymphocytopenia (HP:0010976) | 4.39303434 |
20 | Chronic otitis media (HP:0000389) | 3.96141953 |
21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67160702 |
22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67160702 |
23 | Abnormality of the nasal mucosa (HP:0000433) | 3.64297457 |
24 | Persistence of primary teeth (HP:0006335) | 3.60005300 |
25 | Autoimmune hemolytic anemia (HP:0001890) | 3.59095742 |
26 | Joint swelling (HP:0001386) | 3.54390631 |
27 | Abnormality of eosinophils (HP:0001879) | 3.52051911 |
28 | Lymphopenia (HP:0001888) | 3.47091169 |
29 | Abnormality of the fingertips (HP:0001211) | 3.44675824 |
30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38157228 |
31 | Leukocytosis (HP:0001974) | 3.33965536 |
32 | Myositis (HP:0100614) | 3.32863009 |
33 | Recurrent viral infections (HP:0004429) | 3.29333251 |
34 | Thrombocytosis (HP:0001894) | 3.19575794 |
35 | Thyroiditis (HP:0100646) | 3.16419549 |
36 | Recurrent abscess formation (HP:0002722) | 3.11615828 |
37 | Keratoconjunctivitis (HP:0001096) | 3.05984634 |
38 | Recurrent bacterial skin infections (HP:0005406) | 3.03247002 |
39 | Vasculitis (HP:0002633) | 3.01898567 |
40 | Mediastinal lymphadenopathy (HP:0100721) | 3.00357085 |
41 | * Abnormality of T cell physiology (HP:0011840) | 2.97364675 |
42 | Recurrent sinusitis (HP:0011108) | 2.96431118 |
43 | Bronchitis (HP:0012387) | 2.95993933 |
44 | Arterial thrombosis (HP:0004420) | 2.93103518 |
45 | Lymphoma (HP:0002665) | 2.92107918 |
46 | * IgA deficiency (HP:0002720) | 2.89538279 |
47 | Prolonged bleeding time (HP:0003010) | 2.88854732 |
48 | Chest pain (HP:0100749) | 2.87133144 |
49 | Hemoptysis (HP:0002105) | 2.79571209 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77355256 |
51 | Amaurosis fugax (HP:0100576) | 2.75442494 |
52 | Eosinophilia (HP:0001880) | 2.69294751 |
53 | Pustule (HP:0200039) | 2.68462707 |
54 | Optic neuritis (HP:0100653) | 2.67076816 |
55 | Retrobulbar optic neuritis (HP:0100654) | 2.67076816 |
56 | Stomach cancer (HP:0012126) | 2.64660056 |
57 | Pulmonary infiltrates (HP:0002113) | 2.62825213 |
58 | Abnormality of incisor morphology (HP:0011063) | 2.56924214 |
59 | Hypoplasia of the thymus (HP:0000778) | 2.50222265 |
60 | Obstructive lung disease (HP:0006536) | 2.46962438 |
61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46962438 |
62 | * Increased IgM level (HP:0003496) | 2.45221281 |
63 | Abnormality of the prostate (HP:0008775) | 2.39931250 |
64 | Granulocytopenia (HP:0001913) | 2.38202504 |
65 | Gastrointestinal stroma tumor (HP:0100723) | 2.37367430 |
66 | Orchitis (HP:0100796) | 2.35957818 |
67 | Ureteral stenosis (HP:0000071) | 2.35579799 |
68 | Fatigue (HP:0012378) | 2.34413245 |
69 | Meningitis (HP:0001287) | 2.34129809 |
70 | Abnormality of binocular vision (HP:0011514) | 2.26799342 |
71 | Diplopia (HP:0000651) | 2.26799342 |
72 | Keratitis (HP:0000491) | 2.25097718 |
73 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.22791262 |
74 | Aplastic anemia (HP:0001915) | 2.22186165 |
75 | Hypochromic anemia (HP:0001931) | 2.19082732 |
76 | Episodic fever (HP:0001954) | 2.18960140 |
77 | Pulmonary embolism (HP:0002204) | 2.15841754 |
78 | Emphysema (HP:0002097) | 2.15606479 |
79 | Gingival bleeding (HP:0000225) | 2.14313014 |
80 | Abnormality of the endocardium (HP:0004306) | 2.14306284 |
81 | Pancytopenia (HP:0001876) | 2.13274149 |
82 | Papilledema (HP:0001085) | 2.11875311 |
83 | Ureteral obstruction (HP:0006000) | 2.10705184 |
84 | Recurrent otitis media (HP:0000403) | 2.10702145 |
85 | Recurrent skin infections (HP:0001581) | 2.10298842 |
86 | Pulmonary fibrosis (HP:0002206) | 2.07685084 |
87 | Somatic mutation (HP:0001428) | 2.07496918 |
88 | Gangrene (HP:0100758) | 2.05731565 |
89 | Spontaneous hematomas (HP:0007420) | 2.05601870 |
90 | Abnormality of macrophages (HP:0004311) | 2.03813048 |
91 | Epistaxis (HP:0000421) | 2.01392735 |
92 | * Hypergammaglobulinemia (HP:0010702) | 2.00645167 |
93 | Cutaneous melanoma (HP:0012056) | 2.00263033 |
94 | Peripheral hypomyelination (HP:0007182) | 1.97747830 |
95 | Inflammation of the large intestine (HP:0002037) | 1.95168904 |
96 | Myocardial infarction (HP:0001658) | 1.94813286 |
97 | Basal cell carcinoma (HP:0002671) | 1.94416211 |
98 | Papilloma (HP:0012740) | 1.93852215 |
99 | Verrucae (HP:0200043) | 1.93852215 |
100 | Increased IgE level (HP:0003212) | 1.91411520 |
101 | Encephalitis (HP:0002383) | 1.90415482 |
102 | Frequent falls (HP:0002359) | 1.87272794 |
103 | Chronic sinusitis (HP:0011109) | 1.86833961 |
104 | Gastrointestinal inflammation (HP:0004386) | 1.86335154 |
105 | Hypochromic microcytic anemia (HP:0004840) | 1.85453878 |
106 | Polyneuropathy (HP:0001271) | 1.82533433 |
107 | Alveolar cell carcinoma (HP:0006519) | 1.82273012 |
108 | Autoimmune thrombocytopenia (HP:0001973) | 1.82263226 |
109 | Hypoproteinemia (HP:0003075) | 1.82095127 |
110 | Keratoconjunctivitis sicca (HP:0001097) | 1.82001625 |
111 | Agammaglobulinemia (HP:0004432) | 1.81973000 |
112 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81802524 |
113 | * Neutropenia (HP:0001875) | 1.81127537 |
114 | Acute hepatic failure (HP:0006554) | 1.80503469 |
115 | Anorexia (HP:0002039) | 1.80253582 |
116 | Abnormal pupillary function (HP:0007686) | 1.80115180 |
117 | Arthralgia (HP:0002829) | 1.79944725 |
118 | Prostate neoplasm (HP:0100787) | 1.79445870 |
119 | Abnormality of male internal genitalia (HP:0000022) | 1.78576203 |
120 | Skin rash (HP:0000988) | 1.77150312 |
121 | Abnormal platelet volume (HP:0011876) | 1.77095063 |
122 | Abnormality of the pleura (HP:0002103) | 1.75764244 |
123 | Cheilitis (HP:0100825) | 1.73789615 |
124 | Severe visual impairment (HP:0001141) | 1.73295633 |
125 | Oral leukoplakia (HP:0002745) | 1.71929191 |
126 | Bronchiectasis (HP:0002110) | 1.70386413 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.87561237 |
2 | MAP4K1 | 6.54327217 |
3 | TAOK3 | 5.42406039 |
4 | ZAP70 | 4.37641777 |
5 | ITK | 3.30351666 |
6 | JAK3 | 2.93446101 |
7 | TESK2 | 2.75627897 |
8 | MAP3K12 | 2.62327052 |
9 | IKBKE | 2.34371038 |
10 | MAP3K14 | 2.29673492 |
11 | FGFR4 | 2.21211617 |
12 | PRPF4B | 1.98186591 |
13 | CAMKK2 | 1.95091864 |
14 | KDR | 1.92754627 |
15 | TEC | 1.92050059 |
16 | LCK | 1.88934670 |
17 | RIPK4 | 1.84203820 |
18 | MAP3K11 | 1.78604924 |
19 | TYK2 | 1.74937639 |
20 | STK10 | 1.72232994 |
21 | IKBKB | 1.61259003 |
22 | NUAK1 | 1.54771002 |
23 | TBK1 | 1.48907589 |
24 | JAK1 | 1.46392517 |
25 | NLK | 1.43399864 |
26 | TAOK1 | 1.38200101 |
27 | HCK | 1.37154578 |
28 | CHUK | 1.36891895 |
29 | PRKCQ | 1.28180849 |
30 | PIM2 | 1.25832396 |
31 | FGFR3 | 1.24158664 |
32 | CAMKK1 | 1.23996104 |
33 | TESK1 | 1.23776072 |
34 | BTK | 1.17625000 |
35 | SYK | 1.14587686 |
36 | GRK6 | 1.12975839 |
37 | MAP2K2 | 1.07231147 |
38 | MAP3K10 | 1.07069445 |
39 | CSK | 1.05091314 |
40 | MAP2K3 | 1.00041106 |
41 | PRKCH | 1.00008945 |
42 | ADRBK2 | 0.95507795 |
43 | CSF1R | 0.95329461 |
44 | FGFR1 | 0.95089054 |
45 | RPS6KA4 | 0.94879462 |
46 | MAP3K13 | 0.92585447 |
47 | MAP3K7 | 0.87300020 |
48 | EEF2K | 0.83951828 |
49 | JAK2 | 0.81182127 |
50 | MAPK11 | 0.78693894 |
51 | SIK3 | 0.77447882 |
52 | EIF2AK1 | 0.77056928 |
53 | RPS6KA5 | 0.74114586 |
54 | PIM1 | 0.72934225 |
55 | LYN | 0.71908775 |
56 | TAOK2 | 0.71736000 |
57 | MST4 | 0.70858061 |
58 | FGR | 0.68859696 |
59 | LRRK2 | 0.68318346 |
60 | NME2 | 0.68299825 |
61 | MAP3K3 | 0.66101492 |
62 | SIK2 | 0.62849809 |
63 | PKN2 | 0.61378541 |
64 | CDK12 | 0.55949291 |
65 | TYRO3 | 0.54553377 |
66 | WNK1 | 0.51977024 |
67 | RAF1 | 0.51687354 |
68 | PDGFRB | 0.49157711 |
69 | TGFBR2 | 0.47750702 |
70 | SIK1 | 0.47396408 |
71 | EPHA3 | 0.47281201 |
72 | MARK3 | 0.46407750 |
73 | LIMK1 | 0.46384333 |
74 | TNK2 | 0.45926360 |
75 | IRAK1 | 0.45628324 |
76 | BLK | 0.44627048 |
77 | TLK1 | 0.43678288 |
78 | MAP3K1 | 0.43483466 |
79 | NTRK2 | 0.43449186 |
80 | INSR | 0.43257305 |
81 | IGF1R | 0.42932147 |
82 | RPS6KA1 | 0.42761756 |
83 | EIF2AK3 | 0.42579357 |
84 | MAP4K2 | 0.42342357 |
85 | IRAK4 | 0.41552401 |
86 | TRIB3 | 0.41186262 |
87 | MYLK | 0.40971662 |
88 | ROCK2 | 0.38603632 |
89 | CLK1 | 0.36308052 |
90 | RPS6KA6 | 0.36211277 |
91 | EPHB1 | 0.35743606 |
92 | FYN | 0.35284262 |
93 | PTK2B | 0.35235396 |
94 | SRPK1 | 0.34597576 |
95 | PDK1 | 0.34274755 |
96 | TSSK6 | 0.33368568 |
97 | FES | 0.33357654 |
98 | STK38 | 0.32644666 |
99 | MATK | 0.32344314 |
100 | BRD4 | 0.32153688 |
101 | KIT | 0.32068485 |
102 | CDK8 | 0.31833199 |
103 | ALK | 0.31715658 |
104 | TRPM7 | 0.31658671 |
105 | PAK3 | 0.31082271 |
106 | MARK2 | 0.30617065 |
107 | CAMK4 | 0.29186313 |
108 | TTN | 0.28691253 |
109 | MELK | 0.28242246 |
110 | PINK1 | 0.28194264 |
111 | PIK3CG | 0.27326487 |
112 | PTK6 | 0.26910995 |
113 | CDK9 | 0.26771755 |
114 | MAPKAPK2 | 0.26185088 |
115 | PIK3CA | 0.25599629 |
116 | MAP3K8 | 0.24471741 |
117 | NEK6 | 0.24332016 |
118 | RPS6KC1 | 0.23143982 |
119 | RPS6KL1 | 0.23143982 |
120 | NME1 | 0.22485485 |
121 | PASK | 0.21426052 |
122 | DAPK3 | 0.20241705 |
123 | MAP3K5 | 0.19584298 |
124 | HIPK2 | 0.19554961 |
125 | MAPK8 | 0.18527315 |
126 | CDK4 | 0.18310838 |
127 | MST1R | 0.17656896 |
128 | MAPK3 | 0.16488226 |
129 | DAPK1 | 0.16222651 |
130 | MAP2K6 | 0.16078835 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 5.04013161 |
2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.35080172 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.30443950 |
4 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.25865679 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.81453726 |
6 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.25581145 |
7 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.11149443 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.04055135 |
9 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95130275 |
10 | Measles_Homo sapiens_hsa05162 | 2.85640093 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.72091532 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.09494539 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01689156 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95102670 |
15 | * Asthma_Homo sapiens_hsa05310 | 1.91247760 |
16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.89291826 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83973899 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64149941 |
19 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.56406578 |
20 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.55659043 |
21 | Proteasome_Homo sapiens_hsa03050 | 1.54915303 |
22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54783694 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52588664 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49087846 |
25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41452548 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39053243 |
27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36807389 |
28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36374831 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35275774 |
30 | Hepatitis B_Homo sapiens_hsa05161 | 1.31165225 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25713321 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25371467 |
33 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.21045455 |
34 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20639921 |
35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18088069 |
36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04406133 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03071258 |
38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02655792 |
39 | Shigellosis_Homo sapiens_hsa05131 | 0.99061864 |
40 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95025336 |
41 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94332742 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93252546 |
43 | Apoptosis_Homo sapiens_hsa04210 | 0.93074776 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91656580 |
45 | Legionellosis_Homo sapiens_hsa05134 | 0.86795592 |
46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84971924 |
47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83755891 |
48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82604766 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80570770 |
50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78889947 |
51 | Influenza A_Homo sapiens_hsa05164 | 0.78326784 |
52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77756175 |
53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77468319 |
54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77168569 |
55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74140031 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72595109 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71610342 |
58 | Ribosome_Homo sapiens_hsa03010 | 0.70961809 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64960161 |
60 | Hepatitis C_Homo sapiens_hsa05160 | 0.64482634 |
61 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61395371 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.58517489 |
63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58131928 |
64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57970866 |
65 | Spliceosome_Homo sapiens_hsa03040 | 0.55573690 |
66 | Tuberculosis_Homo sapiens_hsa05152 | 0.55513571 |
67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53188061 |
68 | RNA polymerase_Homo sapiens_hsa03020 | 0.52023071 |
69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48981263 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.48465692 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48192175 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.48183736 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44439643 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44328888 |
75 | RNA degradation_Homo sapiens_hsa03018 | 0.43929698 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42722218 |
77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41868775 |
78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38275392 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.37998696 |
80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34399852 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29441669 |
82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29184861 |
83 | Protein export_Homo sapiens_hsa03060 | 0.29119238 |
84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28564096 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.27944447 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27457811 |
87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26823243 |
88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24584749 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23487777 |
90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21865696 |
91 | * Malaria_Homo sapiens_hsa05144 | 0.21482825 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20221757 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18972442 |
94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18722055 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18050982 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17451509 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17346224 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16736786 |
99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.16674291 |
100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16562482 |
101 | Renin secretion_Homo sapiens_hsa04924 | 0.14302071 |
102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14092001 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12267395 |
104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11712692 |
105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.11386952 |
106 | Prostate cancer_Homo sapiens_hsa05215 | 0.11057648 |
107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10444642 |
108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10310185 |
109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10229422 |
110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.10028500 |
111 | Morphine addiction_Homo sapiens_hsa05032 | 0.09896135 |
112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.08950812 |
113 | RNA transport_Homo sapiens_hsa03013 | 0.07458542 |
114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.06993449 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06586217 |
116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.06499747 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06213154 |
118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.05941553 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02338273 |
120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01671524 |
121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01422218 |
122 | Adherens junction_Homo sapiens_hsa04520 | -0.0172867 |
123 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0080830 |